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Abstract
Purpose The aim of this research is to study the patterns of
ocular involvement in patients with biopsy-proven lung
sarcoidosis and estimate the level of patients’ awareness of
possible ocular complications of sarcoidosis.
Methods Fifty patients with biopsy-proven lung sarcoidosis
were referred from the Department of Respiratory Medi-
cine, University Hospital of Larissa, Greece.
Results The most prominent ocular symptom was foreign
body sensation in 15/50 patients (30%); only 6/50 of our
patients (12%) were completely asymptomatic with respect
to ocular symptoms. Anterior segment findings were:
episcleritis in 8/50 patients (16%), iris nodules in 9/50
patients (18%), and cataract in 19/50 patients (38%).
Periphlebitis was observed in 8/50 patients (16%),
periarteritis in 8/50 patients (16%), epiretinal membrane
in 6/50 patients (12%), and branch retinal vein occlusion
in 7/50 of our patients (14%). Ten out of 50 patients
(20%) had never visited an ophthalmologist before,
whereas eight out of 50 patients (16%) had undergone
an ophthalmic exam more than 2 years ago.
Conclusions Eye involvement is common in patient with
biopsy-proven lung sarcoidosis and may occur even
without prominent ocular symptoms.
Keywords Awareness .Ocular.Perivasculitis.Sarcoidosis.
Uveitis
Introduction
Sarcoidosis is a multisystemic, granulomatous disease of
unknown etiology that is directly characterized by non-
caseating epitheloid granulomas in affected organs [1]. The
disease can affect the skin, nervous system, eye, heart, liver,
and a variety of other organs [2]. The etiology of the
disease is unknown, although genetic, environmental, and
infectious agents have been hypothesized as triggers [3];
sarcoidosis commonly affects young and middle-aged
adults. On presentation, almost 90% of patients will have
an abnormal chest radiograph in the form of infiltrates, not
always associated with clinical symptoms or signs [4].
Ocular manifestations of the disease have been reported in
up to 50% of patients with biopsy-proven disease. Two
peaks of incidence were reported for ocular sarcoidosis
(OS), the first at ages 20–30 years and the second at ages
50–60 years [5, 6]. Uveitis is the most common ocular
manifestation(30%–70%)andispotentiallyvision-threatening
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DOI 10.1007/s12348-011-0029-7[5–7]. The incidence of OS in industrialized countries has
been found to vary, with rates reported from 27% and
20% (in London and New York, respectively) to 11% and
4% (in studies from France and Eastern Europe,
respectively) [8, 9]. Even the pattern of uveitic disease
has been reported to vary, with anterior uveitis being the
predominant in some races (70%–75% in black ones) and
posterior uveitis in others (65%–83% in white ones) [5, 6,
10]. Accurate and prompt diagnosis and treatment are
important in order to preserve visual function [11].
There are limited data in the literature concerning the
patterns of ocular findings in sarcoidosis and patients'
awareness with respect to possible ocular involvement in
sarcoidosis disease. Individual awareness is an important
factor in screening, diagnosis, treatment, compliance, and
prevention of possible ocular and systemic complications.
In our cohort study, patients with biopsy-proven
pulmonary sarcoidosis were included and we studied
the patterns of ocular involvement and estimated the
patients' awareness of possible ocular complications of
sarcoidosis.
Patients and methods
Fifty patients (50) with biopsy-proven pulmonary sarcoidosis
(transbronchial lung biopsy) were included in the study. All
selected subjects were referred from the Department of
Respiratory Medicine of the University Hospital of Larissa,
Greece as part of our study protocol, which was approved by
the Local Ethics Committee; a written informed consent was
obtained from all study participants. This was a prospective
study with the following inclusion criteria: (1) history of
biopsy-proven pulmonary sarcoidosis, (2) ability to clearly
communicate and understand the purpose of this study, (3)
willingness to participate and ability to provide a written
informed consent
In this baseline visit, we recorded demographic data,
past ocular, and medical history and concomitant drug
uptake. Each patient was questioned (using a standardized
questionnaire) about present and past medical and ocular
symptoms (possible irritation, itching, red eye, grittiness,
dry eye symptoms, transient or permanent vision
blurring, history of previous eye surgery) and possible
ocular involvement of sarcoidosis in an effort to
estimate the individual awareness of the disease oph-
thalmic sequelae (i.e., the patient was asked about his/
hers education level, the amount of knowledge about the
possible ocular sequelae of sarcoidosis, and the source
of this information—health providers, textbooks, internet).
All patients underwent complete ophthalmic evaluation
including best-corrected visual acuity (BCVA) with Snellen
charts, and slit-lamp biomicroscopy.
All patients were screened for evidence of keratocon-
junctivitis sicca using Schirmer's tear test without local
anesthesia. More than 15 mm moistening on the filter paper
was considered as normal [12].
Intraocular pressure was recorded with a Goldman
applanation tonometer. The measurement was performed
using a slit lamp, with topical anesthetic and fluorescein.
We performed a non-contact fundus biomicroscopy after
dilating both pupils with tropicamide and phenylephrine
5%. The posterior pole was further evaluated by slit-lamp
biomicroscopy using a 90-diopter lens.
Vitreous haze was graded along an ordinal scale of
0, +0.5, +1, +2, +3, or +4 based on standard photographs
developed by Nussenblatt and associates, with the
modification adopted by the SUN Working Group [13,
14]. In the event of positive ocular findings, the patients
were again examined at regular intervals, depending on the
severity of these findings. In the event of retinal
involvement, we performed fluorescein angiography within
the first week of the baseline visit.
Statistics
Data and descriptive statistics were collected prospectively
for all patients. Means and standard deviations were
computed for continuous variables; frequencies and
percentages were calculated for categorical variables.
Means, standard deviations, frequencies, and percentages
were obtained. Using the chi-square test made comparisons
among categorical variables for the presence of findings.
Comparisonsofcategoricalvariableswithcontinuousvariable
were analyzed with independent samples t test. Snellen visual
acuity was converted to logarithm of the minimum angle of
resolution units for analysis. The data were organized and
analyzed using SSPS version13.0 (SSPS Inc, Chicago III).
Differences giving p values <0.05 were defined as
statistically significant.
Results
A total of 50 Caucasians patients were enrolled, from
February till June 2009. Twenty (20) of them (40%) were
male and 30 (60%) were female. The mean age at
presentation was 40.5±10.7 years. Demographics character-
istics of patients and their education level are presented in
Tables 1 and 2,r e s p e c t i v e l y .
In ten out of 50 patients, a striking 20% had never
visited an ophthalmologist before, whereas eight out of
50 patients (16%) had undergone an ophthalmic exam
more than 2 years ago. The remaining 32 patients have
had an ophthalmic exam within the past 2 years. The
142 J Ophthal Inflamm Infect (2011) 1:141–145mean time elapsed from the last visit to an ophthal-
mologist was 19±18.26 months in our study cohort.
Forty-five out of 50 patients (90%) admitted that they
would visit their ophthalmologist more frequently if
they were diagnosed with a serious ophthalmic condi-
tion. Thirty (30) out of 50 patients (60%) were properly
informed about the possible ocular complications of
their systemic disease.
A direct significant correlation in favor of education
level and awareness of ophthalmic complications of
sarcoidosis was found (p<0.05). Sex (male/female) was
not directly related to the level of awareness of ocular
complications of sarcoidosis (p=0.518).
The most prominent ocular symptom was foreign body
sensation in 15 out of 50 patients (30%); the list of ocular
symptoms encountered in our study cohort is presented in
Table 3. Only six out of 50 (12%) of our study patients
were completely asymptomatic (with respect to ocular
symptoms) at the time of their examination.
Schirmer test was read within normal limits in 24 out
of 50 patients (48%) in both eyes; abnormal readings
were observed in 26 out of 50 patients (52%). Rose
Bengal test was normal at the right eye in 19 patients
(38%) and at the left eye in 21 patients (42%). Differ-
ences in results for both eyes, for Schirmer and Rose
Bengal test, based on sex did not exist (p=0.713 and p=
0.142 respectively).
The median BCVA for all patients was 20/20 in the
better eye and 20/25 in the worse eye. The mean
intraocular pressure using Goldman Applanation Tonom-
eter was within normal limits (12.2±2.5 mmHg) in all of
our study subjects. Four of our patients however had
glaucomatous cupping and were on intraocular pressure
eye drops regularly.
Most frequent anterior segment ocular findings in our
study cohort were episcleritis in eight out of 50 patients
(16%), iris nodules in nine out of 50 patients (18%), and
cataract in 19 out of 50 patients (38%); three out of the
nine patients with iris nodules had cells in the anterior
chamber. Six out of eight patients (75%) appeared with
bilateral episcleritis, three out of nine patients (30%) with
bilateral iris nodules and four out of 19 (20%) with
bilateral cataracts, while the rest of them with unilateral
appearance of each ocular finding. With respect to the
cataract findings, it was not possible to clearly determine
in all cases whether it was due to age, past/present
steroid use, or uncontrolled inflammation.
Posterior segment findings were observed in 35 out of
all patients (70%). Regarding posterior segment findings,
vitreous opacities were observed in 12 out of 50 patients
(24%) and in six out of 12 patients (50%) were observed
bilaterally. Periphlebitis was observed in nine out of 50
patients (16%) and in four out of eight patients (50%)
bilaterally, periarteritis in eight out of 50 patients (16%)
and in two out of eight patients (25%) bilaterally,
epiretinal membrane in six out of 50 patients (12%)
and in two out of six patients (30%) bilaterally, and
branch retinal vein occlusion (BRVO) in seven out of 50
patients (14%) and in three out of seven patients (40%)
bilaterally. Periphlebitis was active in all of our study
cases, with some degree of leaking in the fluorescein
angiography. Two of the seven BRVO cases, were
completely asymptomatic before; in the remaining five
patients, the initial diagnosis was made prior to the
enrollment in this study. The list of ocular clinical
findings encountered in our study cohort is presented in
Table 4.
Table 2 Patients' educational level in the study
Educational level Patients, n
University/college 30
High (secondary) school 18
Primary school 2
Total 50
Table 3 Prevalence of patients' ocular sarcoidosis-related symptoms
in the study
Number of patients Percentage (%)
None 6 12.0
Conjuctival hyperaemia 14 28.0
Itching 3 6.0
Foreign body sensation 15 30.0
Tearing 4 8.0
Floaters/veils 7 14.0
Pain 1 2.0
Blurring vision 12 24
Table 1 Demographic data of patient included in the study
Number (%) Age (years)
Female 30 (60%) 43±10.2
Male 20 (40%) 38±11.2
Total 50 (100%) 40.5±10.7
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We did not find any direct correlation between sex and
present ocular symptoms (p=0.340), but we observed sex-
specific differences in cataract prevalence between males
and females. Fourteen out of 30 female patients (46.7%),
as opposed to only four out of 20 male patients (20%)presented with cataract, and this result was statistically
significant (p=0.022).
We also noted a statistical significant difference in the
occurrence of retinal involvement and the duration of
sarcoidosis: Thirty-seven out of 50 patients (74%) with
lung disease more than 48 months were more likely to have
periphlebitis, periarteritis, epiretinal membrane, or neo-
vascularization as compared to 12 out of 50 patients
(26%) with lung disease duration of less than 48 months;
this result was statistically significant (p=0.032).
Discussion
Sarcoidosis is a multisystem granulomatous disorder.
Ocular manifestations are common in 25–50% of patients
with histologically proven disease [15]. Although ocular
sarcoidosis more commonly presents as an anterior
granulomatous uveitis, a wide spectrum of ocular
involvement exists. Typical posterior segment findings
of sarcoidosis include vitritis with or without inflamma-
tory “snowballs”, retinal periphlebitis, preretinal inflam-
matory nodules, and “candle wax drippings” [10, 16].
Choroidal lesions have also been reported in ocular
sarcoidosis [16, 17].
Guidelines for diagnosis of ocular lesions in sarcoid-
osis are the followings: (1) mutton-fat keratic precip-
itates and/or iris nodules (Koeppe/Busacca), (2)
trabecular meshwork nodules and/or tent-shaped periph-
eral anterior synechia, (3) vitreous opacities (snowball/
string of pearls-like appearance), (4) multiple chorioreti-
nal peripheral lesions, (5) retinal perivasculitis (periphle-
bitis) and/or candlewax retinochoroidal exudates and/or
laser photocoagulation spots-like retinochoroidal atrophy,
(6) optic disc nodule(s)/granuloma(s) and/or solitary
choroidal nodule, and (7) bilaterality [18, 19]. Cases
meeting two or more of the above categories fall into the
clinically suspected sarcoidosis group, entitled to further
testing for histologic confirmation.
In this study, we present the wide spectrum of clinical
presentation of ocular sarcoidosis (Tables 3 and 4). In
addition, we assess and estimate the level of awareness of
ocular involvement, among patients with histological
proven pulmonary sarcoidosis.
Our results demonstrate a direct significant correlation
in favor of education level and awareness of ophthalmic
complications of sarcoidosis. There is no safe conclusion
with respect to whether this awareness stems from
individual perception ability, the fact that an educated
individual has more easily access to various information-
al sources (internet, interaction with medical specialists),
or the quality of information from primary care physi-
cians. The fact that all of our study patients came from
t h es a m eo r i g i n a ls o u r c e( D e p a r t m e n to fR e s p i r a t o r y
Medicine of our Institution) favors the individual ability
and perception as the strongest factor.
We also observed statistically significant sex-specific
differences in cataract prevalence between males and females.
Becauseofinherentdifficultiesingradinglensopacitiesinthis
study, we donot include tabulationsof cataract formation. It is
likely that the higher prevalence of cataract in our female
study population can be partially attributed to their older age,
but even after adjusting for the age difference, the sex
difference in cataract formation still exists. We also noted a
statistical significant difference in the occurrence of retinal
involvement and the duration of sarcoidosis: patients with
lung disease of more than 48 months were more likely to have
periphlebitis, periarteritis, epiretinal membrane, or neovascu-
larization compared to patients with lung disease duration of
less than 48 months.
The differential diagnosis of ocular sarcoidosis is variable
according to the specific clinical manifestations and can mimic
almost any other disease, including anterior, intermediate, or
posterior uveitis, panuveitis, or a masquerade syndrome. Our
study results demonstrate a positive correlation between
patients' education and level of awareness for potentially
vision-robbing sequelae of sarcoidosis. Of course, this finding
may be somewhat biased by the fact that some of our cases
had already experienced a severe ocular involvement (i.e.,
BRVO) and they might have sought some additional
resources for sarcoidosis disease with respect to its ocular
involvement. Despite this limitation, and taking into account
the fact of positive correlation of educational level and
disease awareness, our study results demonstrate that hospital
social services should focus on the correct and prompt
information of ocular sequelae of systemic diseases, for
patient that are educationally deprived.
Table 4 Prevalence of patients' ocular sarcoidosis-related clinical
findings in the study
Number of
patients
Percentage
(%)
Extraocular
Episcleritis 8 16
Intraocular
Iris nodules 9 18
Retinal perivasculitis
(periphlebitis, periarteritis)
16 32
Cataract 19 38
Vitreal opacities
(vitreous haze)
12 24
Epiretinal membrane 6 12
Branch retinal vein
occlusion
71 4
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